Presentation at Society for Immunotherapy of Cancer Annual Meeting
Abstract Title: IMMUNOCERV, an ongoing Phase II trial combining PDS0101, an HPV-specific T cell immunotherapy, with chemotherapy and radiation for treatment of locally advanced cervical cancers
Abstract Number: 674
Presenting Author: Dr. Ann Klopp, The University of Texas MD Anderson Cancer Center

Receive Email Alerts

Join our mailing list to receive the latest news and updates from our team.

Sign up


This website use cookies to facilitate the use of the website, improve its performance and security, personalize the proposed content.